
    
      Eligible patients were trauma patients between the ages of 18 and 75 years old with adequate
      IV access who were able to self-report and communicate pain severity and who were
      consecutively admitted to the trauma intensive care unit (ICU) or trauma step-down units with
      a fracture of the ribs, face, extremities and/or pelvis.

      Eligible patients who signed the informed consent were randomized to either IV Ibuprofen
      (CaldolorÂ®) or Placebo via a computer-generated randomization list.

      Patients had pain measured using a Numerical Rating Scale (NRS) that ranged from 0 (no pain)
      to 10 (worst possible pain)
    
  